Global Therapeutic Medical Device Market Size By Type (Diagnostic Device Class, Treatment Equipment Class), By Application (Hospitals, Health Institutions), By Region, And Segment Forecasts, 2023 to 2...

The Global Therapeutic Medical Device Market was valued at USD 32.6 billion in 2023 and is projected to surpass USD 57.8 billion by 2031, growing at a CAGR of 7.5% during the forecast period of 2023–2031. The growth is primarily driven by increasing prevalence of chronic diseases, technological advancements in healthcare, and rising demand for non-invasive or minimally invasive treatment options. Therapeutic medical devices, which include devices like infusion pumps, neuromodulation systems, and respiratory therapy devices, are gaining significant traction across healthcare institutions due to their efficacy in disease management and patient rehabilitation.

Drivers:

1. Rising Incidence of Chronic and Lifestyle Diseases

The growing global burden of conditions such as diabetes, cardiovascular disorders, and neurological diseases is spurring the demand for effective long-term management through therapeutic medical devices.

2. Advancements in Device Technology

Innovations like wearable therapeutic devices, AI-integrated systems, and remote patient monitoring tools are boosting patient compliance and therapeutic outcomes, making these devices more attractive to both healthcare providers and patients.

3. Growing Geriatric Population

Aging populations globally are more susceptible to chronic ailments, necessitating consistent use of therapeutic devices for pain management, mobility, and ongoing disease therapy.

Restraints:

1. High Cost of Advanced Devices

The initial and maintenance costs of modern therapeutic devices can be prohibitive, especially in lower-income regions, limiting access and adoption.

2. Stringent Regulatory Approvals

Therapeutic devices must undergo rigorous clinical evaluations, slowing down time-to-market for innovative products and adding cost to manufacturers.

Opportunity:

1. Surge in Home Healthcare Demand

There is growing preference for home-based therapeutic treatments, which presents a significant opportunity for portable and user-friendly device innovations.

2. Expansion in Emerging Markets

Improving healthcare infrastructure and increased healthcare expenditure in Asia-Pacific, Latin America, and parts of Africa are expected to create new avenues for market penetration.

Market by System Type Insights:

Among system types, Neuromodulation Devices accounted for the largest market share in 2023. These devices are increasingly used to treat conditions like chronic pain, Parkinson’s disease, and epilepsy. Their growing use in mental health therapies such as depression and anxiety is further propelling this segment. The Respiratory Therapy Devices segment is projected to register the fastest growth, driven by rising cases of respiratory illnesses such as COPD and asthma.

Market by End-use Insights:

The Hospitals & Clinics segment led the market in 2023, contributing over 45% of the global revenue share. These settings are the primary users of advanced therapeutic medical equipment due to higher patient influx and availability of skilled professionals. However, the Homecare Settings segment is poised for notable growth due to rising demand for remote healthcare and patient preference for comfort and convenience.

Market by Regional Insights:

North America dominated the global therapeutic medical device market in 2023, owing to its advanced healthcare infrastructure, strong R&D investments, and favorable reimbursement landscape. Asia-Pacific is anticipated to witness the highest CAGR during the forecast period, fueled by expanding healthcare access, rising disposable incomes, and increasing chronic disease prevalence in countries like China, India, and Japan.

Competitive Scenario:

Key players in the global therapeutic medical device market include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Becton, Dickinson and Company, Baxter International Inc., ResMed Inc., Philips Healthcare, Stryker Corporation, Zimmer Biomet Holdings Inc., and Smith & Nephew plc. These companies are focusing on product innovation, geographical expansion, and strategic acquisitions to reinforce their market presence.

Recent Developments:

In 2023, Medtronic launched a next-gen closed-loop neuromodulation device for chronic pain treatment.

Abbott announced FDA approval for its minimally invasive cardiac therapy device in 2024.

ResMed expanded its respiratory care portfolio with AI-integrated CPAP machines for home-based sleep apnea management in 2023.

Scope of Work – Global Therapeutic Medical Device Market

Report Metric Details

Market Size (2023) USD 32.6 Billion

Projected Market Size (2031) USD 57.8 Billion

CAGR (2023–2031) 7.5%

Market Segments By System Type (Neuromodulation, Respiratory, Infusion Pumps), By End-use (Hospitals, Clinics, Homecare), By Region

Growth Drivers Rising chronic disease burden, advancements in technology, aging population

Opportunities Home healthcare demand, emerging markets expansion

Key Market Developments:

2023: Medtronic plc unveiled its updated spinal cord stimulation system with real-time feedback capabilities.

2024: Philips Healthcare entered a strategic partnership to expand its telehealth therapeutic solutions in Asia.

2023: Stryker Corporation completed a major acquisition of a rehab-focused device firm to diversify its therapy solutions.

FAQs:

1) What is the current market size of the Global Therapeutic Medical Device Market?

The market was valued at USD 32.6 billion in 2023.

2) What is the major growth driver of the Global Therapeutic Medical Device Market?

The increasing prevalence of chronic diseases and advancements in therapeutic technologies are the key growth drivers.

3) Which is the largest region during the forecast period in the Global Therapeutic Medical Device Market?

North America is expected to maintain its dominance due to advanced healthcare infrastructure and strong R&D.

4) Which segment accounted for the largest market share in the Global Therapeutic Medical Device Market?

The Neuromodulation Devices segment accounted for the largest share in 2023.

5) Who are the key market players in the Global Therapeutic Medical Device Market?

Key players include Medtronic plc, Abbott Laboratories, Boston Scientific, Philips Healthcare, and ResMed Inc.